{"id":906165,"date":"2025-11-05T17:31:07","date_gmt":"2025-11-05T22:31:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/"},"modified":"2025-11-05T17:31:07","modified_gmt":"2025-11-05T22:31:07","slug":"form-8-1a-b-opening-position-disclosure","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/","title":{"rendered":"FORM 8.1(a) & (b) (Opening Position Disclosure)"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n DUBLIN<\/span>
\n <\/span>, Nov. 5, 2025<\/span><\/span> \/PRNewswire\/ — Alkermes plc (Nasdaq: ALKS):<\/p>\n

\n IRISH TAKEOVER PANEL<\/b>\n <\/p>\n

\n OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE<\/b>\n <\/p>\n

\n 1.\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION<\/b>\n <\/p>\n

\n\n\n\n\n\n\n\n
\n

\n
\n (a)\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Full name of discloser:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Alkermes plc<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n (b) <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Owner or controller of interests and short<\/b>
\n
\n positions disclosed, if different from 1(a):<\/b>
\n <\/span>\n <\/p>\n

\n \u00a0<\/span>\n <\/p>\n

\n
\n The naming of nominee or vehicle
companies is<\/i>
\n insufficient. For a trust, the
trustee(s), settlor and<\/i>
\n beneficiaries must
be named.<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n N\/A<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n (c)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Name of\u00a0offeror\/offeree in relation to whose<\/b>
\n
\n relevant securities this form relates:<\/b>
\n <\/span>\n <\/p>\n

\n \u00a0<\/span>\n <\/p>\n

\n
\n Use a separate form for each\u00a0offeror\/offeree<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Avadel
Pharmaceuticals\u00a0
plc<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n (d)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Is the discloser the\u00a0offeror or the offeree?<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n OFFEROR<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n (e)\u00a0 <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Date position held:<\/b>
\n <\/span>\n <\/p>\n

\n \u00a0<\/span>\n <\/p>\n

\n
\n The latest practicable date prior to the
disclosure<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 3 November
2025<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n (f)\u00a0\u00a0<\/b>
\n <\/span>\n <\/p>\n

\u00a0<\/p>\n<\/td>\n

\n

\n
\n In addition to the company in 1(c) above, is
the<\/b>
\n discloser also making disclosures in
respect<\/b>
\n of any other party to the offer?<\/b>
\n <\/span>\n <\/p>\n

\n \u00a0<\/span>\n <\/p>\n

\n
\n If it is a cash offer or possible cash offer, state<\/i>
\n
\n “N\/A”<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n N\/A<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n 2.\u00a0\u00a0\u00a0\u00a0\u00a0INTERESTS AND SHORT POSITIONS<\/b>\n <\/p>\n

\n If there are interests and positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.<\/i>\n <\/p>\n

\n Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates <\/b>(Note 1)<\/p>\n

N\/A<\/p>\n

\n All interests and all short positions should be disclosed.<\/i>\n <\/p>\n

\n Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form\u00a08.<\/i>\n <\/p>\n

\n 3.\u00a0\u00a0\u00a0\u00a0\u00a0INTERESTS AND SHORT POSITIONS OF PERSONS ACTING
\u00a0 \u00a0 \u00a0 \u00a0 IN CONCERT WITH THE PARTY MAKING THE DISCLOSURE<\/b>\n <\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Details of any interests and short positions (including directors’<\/b>
\n
\n and other employee options) of any person acting in concert with<\/b>
\n
\n the party making the disclosure:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Interests of J.P. Morgan (together with its members of staff under Rule\u00a0
3.3(b)(v) of Part A of the Irish Takeover Rules), financial advisors to
Alkermes plc, but, for clarity, not held on behalf of Alkermes plc:<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n
\n
\n Party<\/span>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Class of\u00a0
Relevant
Security<\/span>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Number of\u00a0
ordinary
shares held
at midnight
(ET) on
3 November
2025<\/span>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Percentage\u00a0
of total
issued share
capital
(rounded)<\/span>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n 55I, LLC<\/span>\n <\/p>\n<\/td>\n

\n

\n Ordinary\u00a0
shares of
US$0.01
each<\/span>\n <\/p>\n<\/td>\n

\n

\n 53<\/span>\n <\/p>\n<\/td>\n

\n

\n 0.0001\u00a0%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n JPMorgan
Chase Bank,
National
Association<\/span>\n <\/p>\n<\/td>\n

\n

\n Ordinary\u00a0
shares of
US$0.01
each<\/span>\n <\/p>\n<\/td>\n

\n

\n 13,500<\/span>\n <\/p>\n<\/td>\n

\n

\n 0.0139\u00a0%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n TOTAL<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13,553<\/span>\n <\/p>\n<\/td>\n

\n

\n 0.0139\u00a0%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n<\/tr>\n
\n

\n
\n Details of any open stock-settled derivative positions (including traded\u00a0
options), or agreements to purchase or sell relevant securities, should
be\u00a0given on a Supplemental Form 8.<\/i>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n Ap11<\/b>\n <\/p>\n

\n 4. \u00a0 \u00a0 <\/b>
\n OTHER INFORMATION<\/b>\n <\/p>\n

\n (a)\u00a0 \u00a0 <\/b>
\n Indemnity and other dealing arrangements<\/b>\n <\/p>\n

\n\n\n\n\n
\n

\n
\n Details of any indemnity or option arrangement, or any agreement<\/b>
\n
\n or understanding, formal or informal, relating to relevant securities<\/b>
\n
\n which may be an inducement to deal or refrain from dealing<\/b>
\n entered\u00a0
into by the party to the offer making the disclosure or any<\/b>
\n person
acting in concert with it:<\/p>\n

<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Irrevocable commitments and letters of intent should not be included. If<\/i>
\n
\n there are no such agreements, arrangements or understandings, state<\/i>
\n
\n “none”
<\/i>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0<\/span>\n <\/p>\n

\n
\n None<\/i>
\n <\/span>\n <\/p>\n

\n \u00a0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n (b)\u00a0 \u00a0 \u00a0<\/b>
\n Agreements, arrangements or understandings\u00a0
\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 relating to options or derivatives<\/b>\n <\/p>\n

\n\n\n\n
\n

\n
\n Full details of any agreement, arrangement or understanding<\/b>
\n
\n between the person disclosing and any other person relating<\/b>
\n to the
voting rights of any relevant securities under any option<\/b>
\n referred
to on this form or relating to the voting rights or future<\/b>
\n acquisition
or disposal of any relevant securities to which any<\/b>
\n derivative
referred to on this form is referenced. If none, this<\/b>
\n should be stated.\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\u00a0<\/p>\n

\n
\n None<\/i>
\n <\/span>\n <\/p>\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n (c) \u00a0 \u00a0 <\/b>
\n Attachments<\/b>\n <\/p>\n

\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Is a Supplemental Form 8 attached?\u00a0 \u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n YES\/NO<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\u00a0<\/p>\n

\u00a0<\/p>\n

\u00a0<\/p>\n

\n
\n No<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Date of disclosure:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 5 November 2025<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Contact name:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Sandy Coombs, Alkermes<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Telephone number:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n +1 781 609 6377<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Public disclosures under Rule 8.1 of the Rules must be made to a\u00a0
Regulatory Information Service.<\/i>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n Ap12<\/b>\n <\/p>\n

\n NOTES ON FORM 8.1(a) and (b)<\/i>\n <\/p>\n

    \n
  1. \n \u00a0 \u00a0 \u00a0See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) of Part B of the Rules.<\/p>\n

    <\/i>\n <\/li>\n

  2. \n \u00a0 \u00a0 \u00a0See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules.<\/p>\n

    <\/i>\n <\/li>\n

  3. \n \u00a0 \u00a0 \u00a0If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.<\/i><\/p>\n

    For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.<\/i><\/p>\n

    References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.<\/i>\n <\/li>\n<\/ol>\n

    \u00a0<\/p>\n

    \n

    \n
    \n \"Alkermes
    \n <\/a>\n <\/p>\n<\/p><\/div>\n

    \u00a0<\/p>\n

    <\/div>\n

    \n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/form-8-1a–b-opening-position-disclosure-302604930.html<\/a><\/p>\n

    SOURCE Alkermes plc<\/p>\n<\/p><\/div>\n

    \"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

    PR Newswire DUBLIN , Nov. 5, 2025 \/PRNewswire\/ — Alkermes plc (Nasdaq: ALKS): IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1.\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0 Full name of discloser: Alkermes plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): \u00a0 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N\/A (c) Name of\u00a0offeror\/offeree in relation to whose relevant securities this form relates: \u00a0 Use a separate form for each\u00a0offeror\/offeree Avadel Pharmaceuticals\u00a0plc (d) Is the discloser the\u00a0offeror or the offeree? OFFEROR (e)\u00a0 Date position held: \u00a0 … <\/p>\n

    Continue reading “FORM 8.1(a) & (b) (Opening Position Disclosure)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-906165","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFORM 8.1(a) & (b) (Opening Position Disclosure) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FORM 8.1(a) & (b) (Opening Position Disclosure) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire DUBLIN , Nov. 5, 2025 \/PRNewswire\/ — Alkermes plc (Nasdaq: ALKS): IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1.\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0 Full name of discloser: Alkermes plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): \u00a0 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N\/A (c) Name of\u00a0offeror\/offeree in relation to whose relevant securities this form relates: \u00a0 Use a separate form for each\u00a0offeror\/offeree Avadel Pharmaceuticals\u00a0plc (d) Is the discloser the\u00a0offeror or the offeree? OFFEROR (e)\u00a0 Date position held: \u00a0 … Continue reading "FORM 8.1(a) & (b) (Opening Position Disclosure)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-05T22:31:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/616416\/Alkermes_plc_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FORM 8.1(a) & (b) (Opening Position Disclosure)\",\"datePublished\":\"2025-11-05T22:31:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/\"},\"wordCount\":775,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/616416\\\/Alkermes_plc_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/\",\"name\":\"FORM 8.1(a) & (b) (Opening Position Disclosure) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/616416\\\/Alkermes_plc_Logo.jpg\",\"datePublished\":\"2025-11-05T22:31:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/616416\\\/Alkermes_plc_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/616416\\\/Alkermes_plc_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/form-8-1a-b-opening-position-disclosure\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FORM 8.1(a) & (b) (Opening Position Disclosure)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FORM 8.1(a) & (b) (Opening Position Disclosure) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/","og_locale":"en_US","og_type":"article","og_title":"FORM 8.1(a) & (b) (Opening Position Disclosure) - Market Newsdesk","og_description":"PR Newswire DUBLIN , Nov. 5, 2025 \/PRNewswire\/ — Alkermes plc (Nasdaq: ALKS): IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1.\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0 Full name of discloser: Alkermes plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): \u00a0 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N\/A (c) Name of\u00a0offeror\/offeree in relation to whose relevant securities this form relates: \u00a0 Use a separate form for each\u00a0offeror\/offeree Avadel Pharmaceuticals\u00a0plc (d) Is the discloser the\u00a0offeror or the offeree? OFFEROR (e)\u00a0 Date position held: \u00a0 … Continue reading \"FORM 8.1(a) & (b) (Opening Position Disclosure)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-05T22:31:07+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/616416\/Alkermes_plc_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FORM 8.1(a) & (b) (Opening Position Disclosure)","datePublished":"2025-11-05T22:31:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/"},"wordCount":775,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/616416\/Alkermes_plc_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/","name":"FORM 8.1(a) & (b) (Opening Position Disclosure) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/616416\/Alkermes_plc_Logo.jpg","datePublished":"2025-11-05T22:31:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/616416\/Alkermes_plc_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/616416\/Alkermes_plc_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/form-8-1a-b-opening-position-disclosure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FORM 8.1(a) & (b) (Opening Position Disclosure)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/906165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=906165"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/906165\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=906165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=906165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=906165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}